Background The development of accurate urinary biomarkers for non-invasive and cost-
effective detection of primary and recurrent bladder tumours is recognized as one of the …

Aim: To analyze the potential of 14 cancer-associated genes, including six miRNAs, for
bladder cancer (BC) diagnosis in urine. Patients & methods: DNA methylation levels of 14 …

DNA methylation analysis of full void urine and urine pellet seems promising for bladder
cancer (BC) detection and surveillance. Urinary cell-free DNA from urine supernatant is now …

Purpose: This study aims to provide a better set of DNA methylation markers in urine
sediments for sensitive and specific detection of bladder cancer. Experimental Design: Fifty …

Background Highly sensitive and specific urinary biomarkers for the early detection of
bladder cancer (BC) to improve the performance of urinary cytology are needed. Objective …

Background Current standard methods used to detect and monitor bladder cancer (BC) are
invasive or have low sensitivity. This study aimed to develop a urine methylation biomarker …

Background Aberrant DNA methylation status early in carcinogenesis represents a potential
indicator of tumor detection. We would like to establish a DNA methylation biomarker panel …

Background Current non-invasive tests have limited sensitivities and lack capabilities of pre-
operative risk stratification for bladder cancer (BC) diagnosis. We aimed to develop and …

Purpose: The high risk of recurrence after transurethral resection of bladder tumor of
nonmuscle invasive disease requires lifelong treatment and surveillance. Changes in DNA …

BACKGROUND Current methods for the detection and surveillance of bladder cancer (BCa)
are often invasive and/or possess suboptimal sensitivity and specificity, especially in early …